Compare Mitrabahtera Segara Sejati Tbk. (MBSS) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mitrabahtera Segara Sejati Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Mitrabahtera Segara Sejati Tbk. trades at Rp2,890 (market cap 5.04T, 2.48M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Mitrabahtera Segara Sejati Tbk. is far larger — about 48.3× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MBSS | SCPI | |
|---|---|---|
Market Cap | 5.04T | 104.4B |
Volume | 2.48M | — |
Lot | 24.83K | — |
Turnover | 7.17B | — |
Average Price | 2,888.23 | — |
Value | 7.17B | — |
Indicative Equilibrium Price | 2,890 | — |
Indicative Equilibrium Volume | 783 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mitrabahtera Segara Sejati Tbk.
PT Mitrabahtera Segara Sejati Tbk (the company) was established on 24 Mar 1994 based on Notaries Deed No. 107 and the deed of establishment was approved by the the Ministry of Justice dated Nov 6, 1996. The Company’s articles of association has been amended several times, most recently by notarial deed No. 5 of Fathiah Helmi, S.H., dated Dec 13, 2010, concerning among others, the change in the Company’s name, and public offering.
Read more on MBSS →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
